TG Therapeutics | Passivo Circulante

Current Liabilities Alterar Data
AbbVie USD 41.52B 6.75B 2024-03
Amgen USD 19.71B 1.32B 2024-03
Ardelyx USD 56.9M 13.37M 2024-03
Arrowhead Research USD 65.18M 1.45M 2024-03
Bayer EUR 30.63B 1.17B 2024-03
Biogen USD 3.22B 211.5M 2024-03
Corcept Therapeutics USD 97.2M 7.3M 2024-03
Dynavax Technologies USD 56M 6.19M 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
J&J USD 48.72B 4.36B 2024-03
Novartis USD 29.29B 2.9B 2024-03
PTC Therapeutics USD 574.55M 28.55M 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Roche Holding CHF 24.82B 1.38B 2023-12
TG Therapeutics USD 99.68M 42.01M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



TG Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.